Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Sustainability and transformation plan (STP) leads urged to involve pharmacists following £325m budget announcement

Robbie Turner, director for England at the Royal Pharmaceutical Society, has written to all 44 STP leads emphasising the urgent need for pharmacist involvement following budget announcements

Robbie Turner, director for England at the RPS

Source: Courtesy of Robbie Turner

Robbie Turner wrote a letter to all STP leads to make the point that medicines are the most common healthcare intervention in every STP, and that pharmacists are invaluable in helping STPs to manage their costs and improve quality of care

UK chancellor Philip Hammond’s 2017 budget announcement on 8 March 2017 — which allocated £325m to sustainability and transformation plans (STPs), as well as £100m to hospital A&E departments — has prompted Robbie Turner, director for England at the Royal Pharmaceutical Society (RPS), to write to all STP leads encouraging them to fully integrate pharmacists into their activities.

“We have written to all STP leads to emphasise the strategic benefits of including pharmacy,” says Turner, “not least because medicines are one of the biggest investments in any STP budget.”

Every area in England has been placed within one of 44 local ‘footprints’, each of which has developed a STP under the leadership of a named individual. The STPs, prepared by multidisciplinary NHS teams working with local authorities and social care providers, have been developed to focus on the needs of their local population.

The plans aim to streamline care services and improve overall health in the local area, while maintaining “sustainable finances” for the NHS. They cover all aspects of NHS spending in England up to March 2021.

Turner’s letter, sent on 10 March 2017, makes the point that medicines are the most common healthcare intervention in every STP and that pharmacists — as experts in the use of medicines — are invaluable in helping STPs to manage their costs and improve quality of care.

His case for pharmacist involvement is supported with real-world examples, such as those detailed in the ‘General practice forward view’, which was published in April 2016 and aims to place 1,500 additional pharmacists into GP surgeries by 2021.

Turner’s letter also highlights a case in Ealing, west London, detailing a practice of ten GPs in which the employment of an independent prescribing pharmacist released an average of ten GP hours each day. That equates to a potential saving of £4,000 per week.

Other examples highlighted include: giving pharmacists overall responsibility for medicines use in care homes, to help reduce the number of unnecessary prescriptions given to residents; expanding the adoption of the minor ailment service (in which eligible people can receive care and medication from a pharmacist without needing to see their GP first); and including pharmacists in referral pathways, so that patients are offered follow-up consultations from their community pharmacist after their care is transferred (after patient is discharged from hospital, for example).

“For STPs to be truly transformational, they need to include pharmacists as part of their delivery plans,” says Turner, adding that he hopes STP leads will be inspired by the examples in his letter.

The need for pharmacists to be part of multidisciplinary teams, such as those delivering STPs, has also been raised by Sandra Gidley, chair of the RPS English Pharmacy Board, in an opinion piece published in The Pharmaceutical Journal in January 2017.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202445

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Robbie Turner, director for England at the RPS

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.